These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11182823)

  • 1. Involvement of central and peripheral cannabinoid receptors in the regulation of heart resistance to arrhythmogenic effects of epinephrine.
    Ugdyzhekova DS; Davydova YG; Maimeskulova LA; Mechoulam R
    Bull Exp Biol Med; 2000 Nov; 130(11):1087-9. PubMed ID: 11182823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increase of the heart arrhythmogenic resistance and decrease of the myocardial necrosis zone during activation of cannabinoid receptors].
    Krylatov AV; Bernatskaia NA; Maslov LN; Pertwee RG; Mechoulam R; Stefano GB; Sharaevskiĭ MA; Sal'nikova OM
    Ross Fiziol Zh Im I M Sechenova; 2002 May; 88(5):560-7. PubMed ID: 12136723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiarrhythmic properties of a cannabinoid (CB) receptor agonist].
    Maslov LN; Lishmanov IuB; Maĭsmekulova LA; Mechoulam P
    Eksp Klin Farmakol; 2001; 64(3):37-40. PubMed ID: 11558437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB(1) and CB(2) receptors.
    Ugdyzhekova DS; Bernatskaya NA; Stefano JB; Graier VF; Tam SW; Mekhoulam R
    Bull Exp Biol Med; 2001 Mar; 131(3):251-3. PubMed ID: 11427912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach.
    Adami M; Frati P; Bertini S; Kulkarni-Narla A; Brown DR; de Caro G; Coruzzi G; Soldani G
    Br J Pharmacol; 2002 Apr; 135(7):1598-606. PubMed ID: 11934799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones.
    Millns PJ; Chapman V; Kendall DA
    Br J Pharmacol; 2001 Mar; 132(5):969-71. PubMed ID: 11226126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid activity curtails cocaine craving.
    Piomelli D
    Nat Med; 2001 Oct; 7(10):1099-100. PubMed ID: 11590424
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion.
    Krylatov AV; Ugdyzhekova DS; Bernatskaya NA; Maslov LN; Mekhoulam R; Pertwee RG; Stephano GB
    Bull Exp Biol Med; 2001 Jun; 131(6):523-5. PubMed ID: 11586395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cannabinoid mechanism in relapse to cocaine seeking.
    De Vries TJ; Shaham Y; Homberg JR; Crombag H; Schuurman K; Dieben J; Vanderschuren LJ; Schoffelmeer AN
    Nat Med; 2001 Oct; 7(10):1151-4. PubMed ID: 11590440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of cannabinoid receptors in regulation of cardiac tolerance to ischemia and reperfusion].
    Lasukova OV; Maslov LN; Ermakov SIu; Crawford D; Barth F; Krylatov AV; Hanus LO
    Izv Akad Nauk Ser Biol; 2008; (4):471-8. PubMed ID: 18771032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paticipation of cannabinoid receptors in the regulation of cardiac rhythm and cardiac contractility].
    Maslov LN; Ermakov SIu; Lasukova OV; Barzakh EI; Krylatov AV; Crawford D; Serebrov VIu
    Ross Fiziol Zh Im I M Sechenova; 2006 Apr; 92(4):429-39. PubMed ID: 16813149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptors and reward in the rat: a conditioned place preference study.
    Cheer JF; Kendall DA; Marsden CA
    Psychopharmacology (Berl); 2000 Jul; 151(1):25-30. PubMed ID: 10958113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart.
    Krylatov AV; Maslov LN; Lasukova OV; Pertwee RG
    Bull Exp Biol Med; 2005 May; 139(5):558-61. PubMed ID: 16224548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alterations of inotropic function of isolated heart and extent of injury of cardiomyocytes after cannabinoid receptor activation during ischemia and reperfusion].
    Maslov LN; Lasukova OV; Krylatov AV; Lishmanov IuB; Pertwee R
    Ross Fiziol Zh Im I M Sechenova; 2003 Sep; 89(9):1108-16. PubMed ID: 14758634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis.
    Ugdyzhekova DS; Krylatov AV; Bernatskaya NA; Maslov LN; Mechoulam R; Pertwee RG
    Bull Exp Biol Med; 2002 Feb; 133(2):125-6. PubMed ID: 12428278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cannabinoid receptors in the regulation of cardiac contractility during ischemia/reperfusion.
    Maslov LN; Lasukova OV; Krylatov AV; Hanus LO; Pertwee R; Ivanchuk II; Crowford D
    Bull Exp Biol Med; 2006 Nov; 142(5):557-61. PubMed ID: 17415461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism.
    Krylatov AV; Uzhachenko RV; Maslov LN; Bernatskaya NA; Makriyannis A; Mechoulam R; Pertwee RG; Sal'nikova OM; Stefano JB; Lishmanov Y
    Bull Exp Biol Med; 2002 Feb; 133(2):122-4. PubMed ID: 12428277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of ORL1 receptors in the regulation of cardiac resistance to arrhythmogenic effects ].
    Maslov LN; Krylatov AV; Lishmanov IuB; Berger H; Galo G; Ma L; Beyermann M; Solenkova NV; Stakheev DL
    Ross Fiziol Zh Im I M Sechenova; 2003 Apr; 89(4):397-408. PubMed ID: 12966717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice.
    Collins DR; Pertwee RG; Davies SN
    Br J Pharmacol; 1995 Jul; 115(6):869-70. PubMed ID: 7582512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.